Literature DB >> 28386936

Prognostic role of histological regression in primary cutaneous melanoma: a systematic review and meta-analysis.

M R Gualano1, S Osella-Abate2, G Scaioli1, E Marra3, F Bert1, E Faure4, E S Baduel3, E Balagna3, P Quaglino3, M T Fierro3, R Siliquini1, S Ribero3.   

Abstract

The prognostic significance of histological regression in primary melanoma has been debated for many years. We aim to review the evidence to see how histological regression may affect prognosis. A systematic review was performed by searching in MEDLINE, Scopus and the Cochrane Library from 1 January 1966 to 1 August 2015. All studies reporting hazard ratios or data on survival and histological regression were included. Primary random-effects meta-analyses were used to summarize outcome measures. Heterogeneity was assessed using the χ2 -test and I2 -statistic. To assess the potential bias of small studies we used funnel plots and the Begg and Mazumdar adjusted rank correlation method. Summaries of survival outcomes were measured as hazard ratios or relative risk of death at 5 years according to the presence of histological regression of primary melanoma. In total, 183 articles were reviewed out of 1876 retrieved. Ten studies comprising 8557 patients were included. Patients with histological regression had a lower relative risk of death (0·77, 95% confidence interval 0·61-0·97) than those without. Examination of the funnel plot did not provide evidence of publication bias. The results showed that histological regression is a protective factor for survival.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 28386936     DOI: 10.1111/bjd.15552

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.

Authors:  Clio Dessinioti; Niki Dimou; Alan C Geller; Aravella Stergiopoulou; Serigne Lo; Ulrike Keim; Jeffrey E Gershenwald; Lauren E Haydu; Simone Ribero; Pietro Quaglino; Susana Puig; Josep Malvehy; Lidija Kandolf-Sekulovic; Tatjana Radevic; Roland Kaufmann; Laura Meister; Eduardo Nagore; Victor Traves; Grigorios G Champsas; Mihaela Plaka; Brigitte Dreno; Emilie Varey; David Moreno Ramirez; Reinhard Dummer; Joanna Mangana; Axel Hauschild; Friederike Egberts; Ketty Peris; Laura Del Regno; Ana-Maria Forsea; Sabina A Zurac; Ricardo Vieira; Ana Brinca; Iris Zalaudek; Teresa Deinlein; Eleni Linos; Evangelos Evangelou; John F Thompson; Richard A Scolyer; Claus Garbe; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

2.  Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital.

Authors:  Rodolfo David Palacios-Diaz; Blanca de Unamuno-Bustos; Carlos Abril-Pérez; Mónica Pozuelo-Ruiz; Javier Sánchez-Arraez; Ignacio Torres-Navarro; Rafael Botella-Estrada
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

3.  Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.

Authors:  Richard J Straker; Katharine Krupp; Cimarron E Sharon; Alexandra S Thaler; Nicholas J Kelly; Emily Y Chu; David E Elder; Xiaowei Xu; John T Miura; Giorgos C Karakousis
Journal:  Ann Surg Oncol       Date:  2022-03-17       Impact factor: 4.339

Review 4.  Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications.

Authors:  Luca Tonella; Valentina Pala; Renata Ponti; Marco Rubatto; Giuseppe Gallo; Luca Mastorino; Gianluca Avallone; Martina Merli; Andrea Agostini; Paolo Fava; Luca Bertero; Rebecca Senetta; Simona Osella-Abate; Simone Ribero; Maria Teresa Fierro; Pietro Quaglino
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  Poliosis Circumscripta: A Mark of Melanoma.

Authors:  Megan D Schollenberger; Julie E Stein; Janis M Taube; Evan J Lipson
Journal:  Am J Med       Date:  2019-06-23       Impact factor: 5.928

6.  Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.

Authors:  D Zugna; R Senetta; S Osella-Abate; M T Fierro; A Pisacane; A Zaccagna; A Sapino; V Bataille; A Maurichi; F Picciotto; P Cassoni; P Quaglino; S Ribero
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640

Review 7.  Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.

Authors:  David M Hyams; Robert W Cook; Antonio C Buzaid
Journal:  J Surg Oncol       Date:  2018-12-12       Impact factor: 3.454

8.  External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.

Authors:  N A Ipenburg; O E Nieweg; T Ahmed; R van Doorn; R A Scolyer; G V Long; J F Thompson; S Lo
Journal:  Br J Surg       Date:  2019-07-16       Impact factor: 6.939

9.  Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.

Authors:  Maria A Pizzichetta; Daniela Massi; Mario Mandalà; Paola Queirolo; Ignazio Stanganelli; Vincenzo De Giorgi; Giovanni Ghigliotti; Stefano Cavicchini; Pietro Quaglino; Maria T Corradin; Pietro Rubegni; Mauro Alaibac; Stefano Astorino; Fabrizio Ayala; Serena Magi; Laura Mazzoni; Maria Ausilia Manganoni; Renato Talamini; Diego Serraino; Giuseppe Palmieri
Journal:  J Transl Med       Date:  2017-11-07       Impact factor: 5.531

10.  Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.

Authors:  D Verver; D van Klaveren; V Franke; A C J van Akkooi; P Rutkowski; U Keilholz; A M M Eggermont; T Nijsten; D J Grünhagen; C Verhoef
Journal:  Br J Surg       Date:  2018-10-11       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.